Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong(Peking University), Xiaotian Zhang(Peking University), Jieyuan Cai(Peking University), Zhenghang Wang(Peking University), Yanshuo Cao(Peking University), Lin Cong(Peking University), Yakun Wang(Peking University), Boya Wang(Peking University), Zhiruo Zhou(Peking University), Wen‐Fei Li(Sun Yat-sen University), Yelizhati Madeti(Peking University), Huizhen Liu(Sichuan University), Lin Shen(Wenzhou Medical University), Jialin Lu(Peking University), Liyang Mo(Peking University), Siyi He(Peking University), Chao Yu(Guiyang Medical University)
Cited by 90
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234